Glutathione deficiency down-regulates hepatic lipogenesis in rats

Lipids in Health and Disease

Volumn 9, Issue 1, 2010, Pages

  Brandsch, Corinna ^a   Schmidt, Tobias ^a   Behn, Diana ^a   Weiße, Kristin ^a   Mueller, Andreas S ^a   Stangl, Gabriele I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CHOLESTEROL; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID SYNTHASE; GLUTATHIONE; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE 1B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; X BOX BINDING PROTEIN 1; PROTEIN TYROSINE PHOSPHATASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FATTY ACID ANALYSIS; LIPOGENESIS; LIVER METABOLISM; MALE; METABOLIC REGULATION; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; UNFOLDED PROTEIN RESPONSE; ANIMAL; BLOOD; DRUG EFFECT; GENETICS; LIVER; METABOLISM; OXIDATIVE STRESS;

ANIMALS; BUTHIONINE SULFOXIMINE; CHOLESTEROL; DOWN-REGULATION; GLUTATHIONE; LIPOGENESIS; LIVER; MALE; OXIDATIVE STRESS; PROTEIN TYROSINE PHOSPHATASES; RATS; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 77952303910     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-50     Document Type: Article

References (59)

1. Clark JM: The epidemiology of non-alcoholic fatty liver disease in adults. J Clin Gastroenterol 2006, 40:S5-S10.
2. Rector RS, Thyfault JP, Wei Y, Ibdah JA: Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008, 14:185-192.
3. Postic C, Girard J: The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008, 34:643-648.
4. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS: Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Clin Invest 1997, 99:838-845.
5. Ceriello A: Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am Heart J 2004, 147:803-807.
6. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999, 48:1-9.
7. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
8. Sekiya M, Hiraishi A, Touyama M, Sakamoto K: Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem Biophys Res Commun 2008, 375:602-607.
9. Bettzieche A, Brandsch C, Hirche F, Eder K, Stangl GI: L-cysteine downregulates SREBP-1c-regulated lipogenic enzymes expression via glutathione in HepG2 cells. Ann Nutr Metab 2008, 52:196-203.
10. Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 1982, 257:13704-13712.
11. Donohue TM Jr, Curry-MyCoy TV, Todero SL, White RL, Kharbanda KK, Nanji AA, Osna NA: L-buthionine (S, R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury. Alcohol Clin Exp Res 2007, 6:1053-1060.
12. DeLeve L, Kaplowith N: Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991, 52:287-305.
13. Griffith OW: Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999, 27:922-935.
14. Lu SC: Regulation of glutathione synthesis. Curr Top Cell Regul 2000, 36:95-116.
15. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI: The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007, 113:234-258.
16. Watanabe T, Sagisaka H, Arakawa S, Shibaya Y, Watanabe M, Igarashi I, Tanaka K, Totsuka S, Takasaki W, Manabe S: A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S, R) - sulfoximine. J Toxicol Sci 2003, 28:455-469.
17. Drew R, Miners JO: The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem Pharmacol 1984, 33:2989-2994.
18. Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
19. Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999, 274:30028-30032.
20. Shimizu S, Ugi S, Maegawa H, Egawa K, Nishio Y, Yoshizaki T, Shi K, Nagai Y, Morino K, Nemoto K, Nakamura T, Bryer-Ash M, Kashiwagi A: Proteintyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 2003, 278:43095-43101.
21. Barford D, Das AK, Egloff MP: The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 1998, 27:133-164.
22. Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1B. Science 1994, 263:1397-1404.
23. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D: Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003, 423:769-773.
24. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H: Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003, 423:773-777.
25. Barrett WC, DeGnore JP, König S, Fales HM, Keng YF, Zhang ZY, Yim MB, Chock PB: Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 1999, 38:6699-6705.
26. Lee AH, Scapa EF, Cohen DE, Glimcher LH: Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008, 320:1492-1496.
27. Suthanthiran M, Anderson ME, Sharma VK, Meister A: Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphcytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990, 87:3343-3347.
28. Rauscher FM, Sanders RA, Watkins JB: Effects of coenzyme Q10 treatment on antoxidant pathways in normal and streptozotocininduced diabetic rats. J Biochem Mol Tox 2001, 15:41-46.
29. Melo SS, Arantes MR, Meirelles MS, Jordão AA Jr, Vannucchi H: Lipid peroxidation in nicotinamide-deficient and nictoinamidesupplemented rats with streptozotocin-induced diabetes. Acta Diabetol 2000, 37:33-39.
30. Cai J, Sun W, Lu SC: Hormonal and cell density regulation of hepatic ?-glutamylcysteine synthetase heavy and light subunit gene expression. Biochem J 1995, 326:167-172.
31. Urata Y, Yamamoto H, Goto S, Tsushima H, Akazawa S, Yamashita S, Nagataki S, Kondo T: Long exposure to high glucose concentration impairs the responsive expression of ?-glutamylcysteine synthetase by interleukin-1ß and tumor necrosis factor-a in mouse endothelial cells. J Biol Chem 1996, 271:15146-15152.
32. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP: Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm (-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 2002, 277:49446-49452.
33. Giordano G, Afsharinejad Z, Guizzetti M, Vitalone A, Kavanagh TJ, Costa LG: Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency. Toxicol Appl Pharmacol 2007, 219:181-189.
34. Kobayashi T, Watanabe Y, Saito Y, Fujioka D, Nakamura T, Obata JE, Kitta Y, Yano T, Kawabata K, Watanabe K, Mishina H, Ito S, Kugiyama K: Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury. Cardiovasc Res 2010, 85:785-795.
35. Lin CC, Yin MC, Hsu CC, Lin MP: Effect of five cysteine-containing compounds on three lipogenic enzymes in Balb/cA mice consuming a high saturated fat diet. Lipids 2004, 39:843-848.
36. Sivaramakrishnan S, Keerthi K, Gates KS: A chemical model for redox regulation of protein tyrosine phosphatase 1B (PTP1B) activity. J Am Chem Soc 2005, 127:10830-10831.
37. Denu JM, Dixon JE: Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr Opin Chem Biol 1998, 2:633-641.
38. Denu JM, Tanner KG: Redox regulation of protein tyrosine phosphatases by hydrogen peroxide: detecting sulfenic acid intermediates and examining reversible inactivation. Methods Enzymol 2002, 348:297-305.
39. Mueller AS, Klomann SD, Wolf NM, Schneider S, Schmidt R, Spielmann J, Stangl G, Eder K, Pallauf J: Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver. J Nutr 2008, 138:2328-2336.
40. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D: IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002, 415:92-96.
41. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107:881-891.
42. Ron D, Walter P: Signal integration in the endoplasmatic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529.
43. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition ad hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 1993, 123:1939-1951.
44. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999, 274:35832-35839.
45. Horton JD, Bashmakov Y, Shimomura I, Shimano H: Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 1998, 95:5987-5992.
46. Hara A, Radin NS: Lipid extraction of tissues with a low toxicity solvent. Anal Biochem 1978, 90:420-426.
47. De Hoff JL, Davidson JH, Kritchevsky D: An enzymatic assay for determining free and total cholesterol in tissues. Clin Chem 1978, 24:433-435.
48. Griffith OW, Meister A: Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci USA 1985, 82:4668-4672.
49. Aebi HE: Catalase. In Methods of enzymatic analysis Volume 3. Edited by: Bergmeyer HU. Weinheim: VCH Verlagsgesellschaft mbH; 1986:273-286.
50. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
51. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
52. Carlberg I, Mannervik B: Glutathione reductase. Methods Enzymol 1985, 113:484-490.
53. Nepokroeff CM, Lakshmanan MR, Porter JW: Fatty acid synthase from rat liver. Methods Enzymol 1975, 35:37-44.
54. Deutsch J: Glucose-6-Phosphate dehydrogenase. In Methods of enzymatic analysis Volume 3. Edited by: Bergmeyer HU. Weinheim: VCH Verlag Chemie; 1995:190-197.
55. Zhu L, Goldstein B: Use of an Anaerobic Chamber Environment for the Assay of Endogenous Cellular Protein-Tyrosine Phosphatase Activities. Biol Proced Online 2002, 4:1-9.
56. Mueller AS, Bosse AC, Most E, Klomann SD, Schneider S, Pallauf J: Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J Nutr Biochem 2009, 20:235-247.
57. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
58. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
59. Pfaffl MW: A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 2001, 29:e45.